0 XP   0   0   0

Adalta Ltd










Financial Health of Adalta




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Richest
#977 / 1193

Total Sales
#510 / 1193

Making Money
#373 / 1193

Working Efficiently
#763 / 1193

Adalta Ltd
Buy, Hold or Sell?

Should you buy, hold or sell Adalta?

I guess you are interested in Adalta Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Adalta

Let's start. I'm going to help you getting a better view of Adalta Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Adalta Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Adalta Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Adalta Ltd. The closing price on 2022-11-25 was A$0.047 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Adalta Ltd Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Adalta Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Adalta earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Adalta to the Biotechnology industry mean.
  • A Net Profit Margin of -118.4% means that $-1.18 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Adalta Ltd:

  • The MRQ is -118.4%. The company is making a huge loss. -2
  • The TTM is -155.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-118.4%TTM-155.4%+37.0%
TTM-155.4%YOY-392.4%+237.0%
TTM-155.4%5Y-1,651.3%+1,495.9%
5Y-1,651.3%10Y-1,588.3%-63.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-118.4%-223.6%+105.2%
TTM-155.4%-281.7%+126.3%
YOY-392.4%-344.8%-47.6%
5Y-1,651.3%-450.1%-1,201.2%
10Y-1,588.3%-541.0%-1,047.3%
1.1.2. Return on Assets

Shows how efficient Adalta is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Adalta to the Biotechnology industry mean.
  • -22.6% Return on Assets means that Adalta generated $-0.23 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Adalta Ltd:

  • The MRQ is -22.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.6%TTM-14.7%-7.8%
TTM-14.7%YOY-21.8%+7.1%
TTM-14.7%5Y-23.1%+8.4%
5Y-23.1%10Y-17.9%-5.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.6%-9.9%-12.7%
TTM-14.7%-8.9%-5.8%
YOY-21.8%-9.3%-12.5%
5Y-23.1%-11.7%-11.4%
10Y-17.9%-12.7%-5.2%
1.1.3. Return on Equity

Shows how efficient Adalta is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Adalta to the Biotechnology industry mean.
  • -44.7% Return on Equity means Adalta generated $-0.45 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Adalta Ltd:

  • The MRQ is -44.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -25.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-44.7%TTM-25.5%-19.1%
TTM-25.5%YOY-30.0%+4.5%
TTM-25.5%5Y-32.6%+7.1%
5Y-32.6%10Y-24.8%-7.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-44.7%-12.0%-32.7%
TTM-25.5%-11.5%-14.0%
YOY-30.0%-10.8%-19.2%
5Y-32.6%-14.2%-18.4%
10Y-24.8%-15.2%-9.6%

1.2. Operating Efficiency of Adalta Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Adalta is operating .

  • Measures how much profit Adalta makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Adalta to the Biotechnology industry mean.
  • An Operating Margin of -59.5% means the company generated $-0.59  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Adalta Ltd:

  • The MRQ is -59.5%. The company is operating very inefficient. -2
  • The TTM is -76.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-59.5%TTM-76.5%+17.0%
TTM-76.5%YOY-310.7%+234.2%
TTM-76.5%5Y-1,818.0%+1,741.5%
5Y-1,818.0%10Y-1,817.8%-0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-59.5%-207.3%+147.8%
TTM-76.5%-271.0%+194.5%
YOY-310.7%-325.9%+15.2%
5Y-1,818.0%-454.0%-1,364.0%
10Y-1,817.8%-537.1%-1,280.7%
1.2.2. Operating Ratio

Measures how efficient Adalta is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Adalta Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY3.337-3.337
TTM-5Y18.136-18.136
5Y18.13610Y18.041+0.096
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
YOY3.3373.604-0.267
5Y18.1365.132+13.004
10Y18.0416.371+11.670

1.3. Liquidity of Adalta Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Adalta is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.91 means the company has $2.91 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Adalta Ltd:

  • The MRQ is 2.912. The company is able to pay all its short-term debts. +1
  • The TTM is 2.798. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.912TTM2.798+0.114
TTM2.798YOY5.051-2.253
TTM2.7985Y5.032-2.233
5Y5.03210Y6.337-1.306
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9125.117-2.205
TTM2.7985.755-2.957
YOY5.0515.854-0.803
5Y5.0326.511-1.479
10Y6.3376.222+0.115
1.3.2. Quick Ratio

Measures if Adalta is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Adalta to the Biotechnology industry mean.
  • A Quick Ratio of 2.90 means the company can pay off $2.90 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Adalta Ltd:

  • The MRQ is 2.897. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.563. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.897TTM1.563+1.334
TTM1.563YOY2.842-1.278
TTM1.5635Y3.060-1.497
5Y3.06010Y3.488-0.428
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8974.284-1.387
TTM1.5634.664-3.101
YOY2.8424.787-1.945
5Y3.0605.218-2.158
10Y3.4885.182-1.694

1.4. Solvency of Adalta Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Adalta assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Adalta to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.49 means that Adalta assets are financed with 49.5% credit (debt) and the remaining percentage (100% - 49.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Adalta Ltd:

  • The MRQ is 0.495. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.382. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.495TTM0.382+0.113
TTM0.382YOY0.262+0.120
TTM0.3825Y0.266+0.116
5Y0.26610Y0.214+0.053
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4950.278+0.217
TTM0.3820.277+0.105
YOY0.2620.306-0.044
5Y0.2660.367-0.101
10Y0.2140.403-0.189
1.4.2. Debt to Equity Ratio

Measures if Adalta is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Adalta to the Biotechnology industry mean.
  • A Debt to Equity ratio of 98.0% means that company has $0.98 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Adalta Ltd:

  • The MRQ is 0.980. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.643. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.980TTM0.643+0.337
TTM0.643YOY0.406+0.237
TTM0.6435Y0.410+0.233
5Y0.41010Y0.319+0.091
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9800.315+0.665
TTM0.6430.317+0.326
YOY0.4060.319+0.087
5Y0.4100.403+0.007
10Y0.3190.462-0.143

2. Market Valuation of Adalta Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Adalta generates.

  • Above 15 is considered overpriced but always compare Adalta to the Biotechnology industry mean.
  • A PE ratio of -14.13 means the investor is paying $-14.13 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Adalta Ltd:

  • The EOD is -12.298. Company is losing money. -2
  • The MRQ is -14.129. Company is losing money. -2
  • The TTM is -17.001. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-12.298MRQ-14.129+1.832
MRQ-14.129TTM-17.001+2.871
TTM-17.001YOY-49.463+32.463
TTM-17.0015Y-2,309.648+2,292.648
5Y-2,309.64810Y-1,673.189-636.459
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.298-8.986-3.312
MRQ-14.129-9.792-4.337
TTM-17.001-16.243-0.758
YOY-49.463-20.876-28.587
5Y-2,309.648-16.665-2,292.983
10Y-1,673.189-14.732-1,658.457
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Adalta.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Adalta Ltd:

  • The MRQ is 99.887. Seems overpriced? -1
  • The TTM is -4.300. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ99.887TTM-4.300+104.186
TTM-4.300YOY-6.569+2.269
TTM-4.3005Y43.932-48.232
5Y43.93210Y38.134+5.798
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ99.887-0.032+99.919
TTM-4.3000.004-4.304
YOY-6.5690.016-6.585
5Y43.9320.006+43.926
10Y38.1340.003+38.131

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Adalta is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.15 means the investor is paying $3.15 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Adalta Ltd:

  • The EOD is 2.745. Good. +1
  • The MRQ is 3.154. Neutral. Compare to industry.
  • The TTM is 4.109. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD2.745MRQ3.154-0.409
MRQ3.154TTM4.109-0.955
TTM4.109YOY7.325-3.216
TTM4.1095Y10.684-6.575
5Y10.68410Y8.885+1.800
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.7451.835+0.910
MRQ3.1542.006+1.148
TTM4.1092.774+1.335
YOY7.3253.453+3.872
5Y10.6842.713+7.971
10Y8.8852.402+6.483
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Adalta Ltd.


4. Summary

4.1. Key Performance Indicators

The key performance indicators of Adalta Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.000-0.001+210%0.002-112%0.000+46%0.001-142%
Book Value Growth--0.2020.293-31%0.384-48%0.282-28%0.346-42%
Book Value Per Share--0.0170.018-5%0.020-13%0.016+4%0.016+9%
Book Value Per Share Growth---0.015-0.046+206%0.088-117%-0.063+319%0.031-149%
Current Ratio--2.9122.798+4%5.051-42%5.032-42%6.337-54%
Debt To Asset Ratio--0.4950.382+29%0.262+89%0.266+86%0.214+132%
Debt To Equity Ratio--0.9800.643+52%0.406+141%0.410+139%0.319+207%
Dividend Per Share----0%-0%-0%-0%
Eps---0.004-0.004+17%-0.004+17%-0.005+33%-0.004+3%
Eps Growth---0.141-0.037-74%0.509-128%154.166-100%128.555-100%
Gross Profit Margin--1.0000.500+100%0.750+33%0.855+17%0.754+33%
Net Profit Margin---1.184-1.554+31%-3.924+231%-16.513+1294%-15.883+1241%
Operating Margin---0.595-0.765+29%-3.107+422%-18.180+2956%-18.178+2956%
Operating Ratio----0%3.337-100%18.136-100%18.041-100%
Pb Ratio2.745-15%3.1544.109-23%7.325-57%10.684-70%8.885-64%
Pe Ratio-12.298+13%-14.129-17.001+20%-49.463+250%-2309.648+16246%-1673.189+11742%
Peg Ratio--99.887-4.300+104%-6.569+107%43.932+127%38.134+162%
Price Per Share0.047-15%0.0540.075-28%0.135-60%0.162-67%0.148-63%
Price To Total Gains Ratio-181.582+13%-208.626-117.877-43%-16.831-92%-2058285.247+986493%-1661267.915+796192%
Profit Growth---100.000-100.0000%-70.005-30%-45.331-55%-44.172-56%
Quick Ratio--2.8971.563+85%2.842+2%3.060-5%3.488-17%
Return On Assets---0.226-0.147-35%-0.218-3%-0.231+2%-0.179-21%
Return On Equity---0.447-0.255-43%-0.300-33%-0.326-27%-0.248-45%
Revenue Growth--1.0001.0000%0.732+37%-8.239+924%-6.684+768%
Total Gains Per Share--0.000-0.001+210%0.002-112%0.000+46%0.001-142%
Total Gains Per Share Growth---1.000-1.0000%--100%63327.055-100%45802.142-100%
Usd Book Value--3631033.4514132230.054-12%4155057.548-13%3540990.706+3%3379063.081+7%
Usd Book Value Change Per Share--0.000-0.001+210%0.001-112%0.000+46%0.000-142%
Usd Book Value Per Share--0.0120.012-5%0.013-13%0.011+4%0.011+9%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.003-0.003+17%-0.003+17%-0.003+33%-0.003+3%
Usd Price Per Share0.032-15%0.0360.050-28%0.091-60%0.110-67%0.100-63%
Usd Profit---1621259.401-1022946.963-37%-1203361.362-26%-1064823.728-34%-839122.609-48%
Usd Revenue--1369075.796465013.943+194%698941.958+96%540402.023+153%499167.493+174%
Usd Total Gains Per Share--0.000-0.001+210%0.001-112%0.000+46%0.000-142%
 EOD+3 -2MRQTTM+15 -14YOY+11 -225Y+20 -1310Y+14 -19

4.2. Fundamental Score

Let's check the fundamental score of Adalta Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-12.298
Price to Book Ratio (EOD)Between0-12.745
Net Profit Margin (MRQ)Greater than0-1.184
Operating Margin (MRQ)Greater than0-0.595
Quick Ratio (MRQ)Greater than12.897
Current Ratio (MRQ)Greater than12.912
Debt to Asset Ratio (MRQ)Less than10.495
Debt to Equity Ratio (MRQ)Less than10.980
Return on Equity (MRQ)Greater than0.15-0.447
Return on Assets (MRQ)Greater than0.05-0.226
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Adalta Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.299
Ma 20Greater thanMa 500.048
Ma 50Greater thanMa 1000.049
Ma 100Greater thanMa 2000.049
OpenGreater thanClose0.047
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets10,649
Total Liabilities5,270
Total Stockholder Equity5,379
 As reported
Total Liabilities 5,270
Total Stockholder Equity+ 5,379
Total Assets = 10,649

Assets

Total Assets10,649
Total Current Assets10,585
Long-term Assets10,585
Total Current Assets
Cash And Cash Equivalents 8,738
Net Receivables 1,790
Other Current Assets 57
Total Current Assets  (as reported)10,585
Total Current Assets  (calculated)10,585
+/-0
Long-term Assets
Property Plant Equipment 64
Long-term Assets  (as reported)64
Long-term Assets  (calculated)64
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,634
Long-term Liabilities1,636
Total Stockholder Equity5,379
Total Current Liabilities
Short-term Debt 2,390
Short Long Term Debt 2,390
Accounts payable 555
Other Current Liabilities 689
Total Current Liabilities  (as reported)3,634
Total Current Liabilities  (calculated)6,024
+/- 2,390
Long-term Liabilities
Long term Debt Total 1,613
Other Liabilities 22
Long-term Liabilities  (as reported)1,636
Long-term Liabilities  (calculated)1,636
+/- 0
Total Stockholder Equity
Common Stock41,011
Retained Earnings -37,288
Other Stockholders Equity 1,655
Total Stockholder Equity (as reported)5,379
Total Stockholder Equity (calculated)5,379
+/-0
Other
Capital Stock41,011
Cash And Equivalents8,661
Cash and Short Term Investments 8,738
Common Stock Shares Outstanding 314,185
Liabilities and Stockholders Equity 10,649
Net Debt -4,736
Net Invested Capital 9,381
Net Tangible Assets 5,379
Net Working Capital 6,950
Short Long Term Debt Total 4,003



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302014-06-302013-06-302012-06-30
> Total Assets 
1,212
608
460
89
0
909
1,383
1,383
8,909
8,909
8,090
8,090
5,475
5,457
4,439
4,439
5,675
5,675
9,310
9,310
5,354
5,354
0
6,907
0
8,505
0
9,049
0
10,093
0
10,649
10,649010,09309,04908,50506,90705,3545,3549,3109,3105,6755,6754,4394,4395,4575,4758,0908,0908,9098,9091,3831,3839090894606081,212
   > Total Current Assets 
0
0
0
0
0
0
0
0
8,907
8,907
8,087
8,087
5,455
5,455
4,436
4,436
5,510
5,510
9,169
9,169
5,158
5,158
6,731
6,731
8,342
8,342
8,978
8,978
10,023
10,023
10,585
10,585
10,58510,58510,02310,0238,9788,9788,3428,3426,7316,7315,1585,1589,1699,1695,5105,5104,4364,4365,4555,4558,0878,0878,9078,90700000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
8,777
8,777
6,225
6,225
5,263
5,263
2,306
2,306
5,359
5,359
5,556
5,556
5,025
5,025
0
3,367
0
8,064
0
5,791
0
9,078
0
8,738
8,73809,07805,79108,06403,36705,0255,0255,5565,5565,3595,3592,3062,3065,2635,2636,2256,2258,7778,77700000000
       Net Receivables 
20
31
76
47
0
14
763
763
130
130
1,840
1,863
192
192
2,081
2,081
151
151
3,578
3,578
133
133
3,311
3,311
278
278
2,977
2,977
866
866
1,671
1,790
1,7901,6718668662,9772,9772782783,3113,3111331333,5783,5781511512,0812,0811921921,8631,84013013076376314047763120
       Other Current Assets 
0
0
0
6
0
5
135
135
0
0
23
23
0
0
50
50
0
0
0
36
0
0
0
53
0
0
78
209
78
78
135
57
57135787820978005300036000505000232300135135506000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
3
0
0
0
141
0
0
0
177
0
0
0
72
0
0
0
64
64000720001770001410003000300000000000
       Property Plant Equipment 
3
2
2
1
0
1
0
0
2
2
0
0
0
0
0
0
162
162
138
138
118
118
99
99
84
84
72
72
70
70
64
64
646470707272848499991181181381381621620000002200101223
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
78
0
0
0
0
0
0
0
0
000000007800030000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
3
3
21
3
3
3
3
3
3
3
78
78
78
78
78
78
0
0
0
0
0
0
000000787878787878333333321330000000000
> Total Liabilities 
178
335
287
261
0
114
215
215
597
597
345
345
1,017
999
366
366
759
759
1,819
1,819
1,946
1,946
0
3,205
0
1,239
0
2,663
0
3,733
0
5,270
5,27003,73302,66301,23903,20501,9461,9461,8191,8197597593663669991,0173453455975972152151140261287335178
   > Total Current Liabilities 
172
324
287
261
0
114
215
215
597
597
345
345
999
999
366
366
759
759
1,819
1,819
1,946
1,946
3,205
3,205
1,239
1,239
2,663
2,663
3,733
3,733
3,634
3,634
3,6343,6343,7333,7332,6632,6631,2391,2393,2053,2051,9461,9461,8191,8197597593663669999993453455975972152151140261287324172
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
966
0
2,191
0
0
0
1,687
0
2,401
0
2,390
2,39002,40101,6870002,1910966000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,191
0
0
0
1,687
0
0
0
2,390
2,3900001,6870002,19100000000000000000000000
       Accounts payable 
0
0
0
0
0
0
30
30
544
544
10
10
934
934
75
75
680
680
1,511
1,511
967
967
541
541
1,070
1,070
216
216
1,217
1,217
555
555
5555551,2171,2172162161,0701,0705415419679671,5111,511680680757593493410105445443030000000
       Other Current Liabilities 
172
324
287
262
0
114
186
186
53
53
334
334
65
65
41
292
0
0
19
308
13
13
175
473
114
114
70
760
4
4
55
689
6895544760701141144731751313308190029241656533433453531861861140262287324172
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,636
1,6360000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,613
1,6130000000000000000000000000000000
> Total Stockholder Equity
1,034
273
173
0
706
795
1,168
1,168
8,312
8,312
7,745
7,745
4,458
4,458
4,073
4,073
4,916
4,916
7,491
7,491
3,408
3,408
0
3,702
0
7,265
0
6,386
0
6,359
0
5,379
5,37906,35906,38607,26503,70203,4083,4087,4917,4914,9164,9164,0734,0734,4584,4587,7457,7458,3128,3121,1681,16879570601732731,034
   Retained Earnings -37,288-37,288-34,886-34,886-31,227-31,227-30,109-30,109-25,598-25,598-25,596-25,596-19,592-19,592-17,079-17,300-13,674-13,674-13,116-13,228-9,819-9,819-9,252-9,25200000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
4
0
0
0
173
0
0
0
274
0
0
0
864
0
0
0
1,381
0
0
0
1,655
1,6550001,381000864000274000173000400000000000
   Capital Surplus 00000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-06-30)

Gross Profit (+$)
totalRevenue988
Cost of Revenue--
Gross Profit988988
 
Operating Income (+$)
Gross Profit988
Operating Expense-8,753
Operating Income-7,765-7,765
 
Operating Expense (+$)
Research Development4,128
Selling General Administrative4,331
Selling And Marketing Expenses-
Operating Expense8,7538,459
 
Net Interest Income (+$)
Interest Income2
Interest Expense-111
Net Interest Income-110-110
 
Pretax Income (+$)
Operating Income-7,765
Net Interest Income-110
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-6,061-9,468
EBIT - interestExpense = -6,061
-6,061
-5,950
Interest Expense111
Earnings Before Interest and Taxes (ebit)-5,950-5,950
Earnings Before Interest and Taxes (ebitda)-5,917
 
After tax Income (+$)
Income Before Tax-6,061
Tax Provision-0
Net Income From Continuing Ops-6,061-6,061
Net Income-6,061
Net Income Applicable To Common Shares-6,061
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net1,704110
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
MBB.XETRA
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MBB.XETRA.

MBB.XETRA Daily Candlestick Chart
VIKASWSP.BSE
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VIKASWSP.BSE.

VIKASWSP.BSE Daily Candlestick Chart
H5E.XETRA
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of H5E.XETRA.

H5E.XETRA Daily Candlestick Chart
SYBR.XETRA
2 minutes ago

I found you a Death Cross on the daily chart of SYBR.XETRA.

SYBR.XETRA Daily Candlestick Chart
REP.XETRA
3 minutes ago

I found you a Golden Cross on the daily chart of REP.XETRA.

REP.XETRA Daily Candlestick Chart
FAA.XETRA
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FAA.XETRA.

FAA.XETRA Daily Candlestick Chart
DVGTR.INDX
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DVGTR.INDX.

DVGTR.INDX Daily Candlestick Chart
BUK100P.INDX
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BUK100P.INDX.

BUK100P.INDX Daily Candlestick Chart
GXX.V
11 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GXX.V.

GXX.V Daily Candlestick Chart
AQS.V
11 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of AQS.V.

AQS.V Daily Candlestick Chart
VOS.XETRA
12 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOS.XETRA.

VOS.XETRA Daily Candlestick Chart
TRD7.XETRA
13 minutes ago

I found you a Death Cross on the daily chart of TRD7.XETRA.

TRD7.XETRA Daily Candlestick Chart
HEI.XETRA
16 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HEI.XETRA.

HEI.XETRA Daily Candlestick Chart
TAEH.XETRA
16 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TAEH.XETRA.

TAEH.XETRA Daily Candlestick Chart
SMLK.XETRA
16 minutes ago

I found you a Golden Cross on the daily chart of SMLK.XETRA.

SMLK.XETRA Daily Candlestick Chart
EN4C.XETRA
16 minutes ago

I found you a Death Cross on the daily chart of EN4C.XETRA.

EN4C.XETRA Daily Candlestick Chart
EB3M.XETRA
16 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of EB3M.XETRA.

EB3M.XETRA Daily Candlestick Chart
VRL.XETRA
21 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of VRL.XETRA.

VRL.XETRA Daily Candlestick Chart
AIL.XETRA
21 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AIL.XETRA.

AIL.XETRA Daily Candlestick Chart
NCB.XETRA
21 minutes ago

I found you a Golden Cross on the daily chart of NCB.XETRA.

NCB.XETRA Daily Candlestick Chart
STO3.XETRA
22 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STO3.XETRA.

STO3.XETRA Daily Candlestick Chart
TAHY.LSE
22 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TAHY.LSE.

TAHY.LSE Daily Candlestick Chart
TAGH.LSE
22 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TAGH.LSE.

TAGH.LSE Daily Candlestick Chart
ICGB.XETRA
22 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ICGB.XETRA.

ICGB.XETRA Daily Candlestick Chart